AHK-CU 100MG

In cellular bioenergetics and hair follicle biology research, high-capacity copper complex peptides are widely evaluated for their role in follicular proliferation and extracellular matrix synthesis. The AHK-Cu 100mg peptide formulation represents a large-format copper-binding tripeptide (Ala-His-Lys-Cu) engineered specifically for high-throughput laboratory models and extended longitudinal assays.

By delivering bioavailable copper directly to dermal cells, the AHK-Cu copper tripeptide sequence provides researchers with a refined molecular tool to study cellular signaling, microvascular development around hair roots, and targeted collagen production without frequent lot-switching.

Technical Specifications & Product Details

Research Context & Scientific Applications

Reference Literature Focus

In scientific literature, research evaluating AHK-Cu centers on its high affinity for hair follicle dermal papilla cells. Key mechanisms investigated in non-clinical studies include:

• Dermal Papilla Cell Proliferation: Upregulation of cell growth cycles and inhibition of apoptotic signaling in hair follicle cells.
• Vascular Endothelial Growth Factor (VEGF): Stimulation of localized microvascular formation to support nutrient supply around hair roots.
• Extracellular Matrix Support: Promotion of collagen synthesis and structural protein maintenance in dermal tissues.

High-Capacity 100mg Format Advantage

While standard 50mg vials serve initial exploratory assays, the AHK-Cu 100mg vial allows high-volume research teams to maintain an identical lot baseline across extended trial arms. Preparing stock solutions from a single 100mg source reduces compounding variability in multi-sample studies.

Commonly Matched Compounds

In multi-pathway tissue and scalp research models, AHK-Cu is frequently paired with:

• GHK-Cu: Combined to evaluate dual hair follicle stimulation alongside systemic dermal matrix remodeling.
• BPC-157: Studied together in tissue injury models to observe microvascular repair and cellular regeneration.
• Biotinoyl Tripeptide-1: Evaluated in topical vehicle models to measure hair anchoring and structural protein expression.

Compliance Notice: AHK-Cu 100mg is designated strictly for laboratory research, in vitro testing, and non-clinical scientific evaluation. It is not approved for human consumption, direct medical treatment, or clinical diagnostic use.

Dosing & Protocol Guidelines

Peptide Handling Reference

Copper tripeptides are sensitive to drastic pH shifts, ultraviolet light, thermal fluctuations, and strong chelating agents. Exposure to acidic conditions can cause copper ions to detach from the amino acid backbone, rendering the compound ineffective. Handle all research vials with care.

Reconstitution Protocol

To properly reconstitute a high-mass 100mg vial of AHK-Cu in a laboratory setting, follow this standardized sequence:

1. Thermal Equalization
   Prerequisite
   Remove the lyophilized 100mg vial from cold storage. Allow the glass container to rest naturally at room temperature for 15 to 20 minutes prior to introducing diluent.
2. Slow Solvent Introduction
   Dilution
   Sanitize the rubber stopper with an alcohol wipe. Using a sterile syringe, slowly introduce bacteriostatic water down the interior glass wall of the vial. Avoid directing the liquid stream straight onto the powder cake.
3. Gentle Swirling
   Dissolution
   Do not shake the vial. Gently roll the vial between your palms or swirl it smoothly in circles until the powder dissolves completely into a clear, light blue liquid.

Storage Requirements

• Unreconstituted Powder: Store long-term in a laboratory freezer at -20^\circ\text{C}, protected from direct light, to maintain structural stability for up to 24 months.
• Reconstituted Liquid Solution: Store continuously in a laboratory refrigerator between 2^\circ\text{C} and 8^\circ\text{C}. Protect from direct light. For optimal experimental accuracy, utilize liquid solutions within 28 days of preparation.

Side Effects & Safety Observations

Safety Observations

Data drawn from preclinical and cellular models demonstrate a favorable safety profile across laboratory assays:

• Localized Response: Minor, transient surface redness or mild irritation may occur at application or administration sites in animal models.
• Low Cytotoxicity: Excellent tolerability in dermal papilla cell cultures when maintained within standard micromolar concentration parameters.
• Metabolic Clearance: Soluble peptide complexes are processed through standard cellular turnover pathways without evidence of systemic copper accumulation at baseline research dosages.

Contraindications

Research protocols incorporating AHK-Cu should exclude experimental setups displaying:

• Known hypersensitivity to copper-containing compounds or synthetic peptides.
• Co-application with strong acids (such as L-ascorbic acid or alpha hydroxy acids) in liquid solutions, which denature the peptide structure.
• Pregnancy or lactation models due to an absence of comprehensive embryonic exposure data.

Interaction Review

Mixing AHK-Cu directly in solution with strong chelating agents (such as EDTA) or ascorbic acid will strip the bound copper ion from the tripeptide. Always verify compatibility in small assay volumes before combining AHK-Cu with other active compounds in a single vehicle.

COA & Testing Integrity

Certificate of Analysis (COA)

To guarantee experimental accuracy and batch consistency, every lot of AHK-Cu 100mg must undergo analytical verification by an independent, third-party laboratory. A fully compliant COA verifies:

1. Mass Spectrometry (MS): Confirms the exact molecular weight and amino acid sequence (Ala-His-Lys) complexed with copper.
2. High-Performance Liquid Chromatography (HPLC): Measures the absolute purity level of the batch, ensuring it meets or exceeds the required 98% purity benchmark without synthesis contaminants.

Quality Inspection Checklist

Prior to introducing a new batch into an active research sequence, confirm the following parameters:

• The protective seal is fully intact and shows no signs of physical tampering.
• Third-party MS and HPLC test reports correspond directly to the lot number printed on the vial label.
• The lyophilized cake is dry, uniform, and presents a light blue appearance without signs of moisture or discoloration.
• Post-reconstitution liquid appears transparent light blue and free of cloudiness, precipitation, or suspended particles.